# OnCo record michael-dickinson (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/michael-dickinson/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "michael-dickinson" ;
  schema:name "Michael Dickinson"@en ;
  schema:description "Led the pivotal glofitamab trial, establishing off-the-shelf bispecific antibodies for relapsed large B-cell lymphoma."@en ;
  schema:url <https://onco.cc/people/michael-dickinson/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Dickinson%20MJ%5BAuthor%5D%20glofitamab> ;
  onco:tag "lymphoma", "bispecific", "australia" ;
  schema:jobTitle "Lead, Aggressive Lymphoma Program, Peter MacCallum Cancer Centre and Royal Melbourne Hospital" ;
  schema:sameAs <https://orcid.org/0000-0002-1492-5966> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/glofitamab/> ;
  onco:institutions <https://onco.cc/institutions/peter-mac/> ;
  onco:trials <https://onco.cc/trials/starglo/> ;
  schema:affiliation <https://onco.cc/institutions/peter-mac/> .